Low-dose preparative regimen and allogeneic stem cell transplantation in patients with multiple myeloma relapsing after autografting.

被引：0
|
作者：
Einsele, H
Bamberg, M
Schäfer, HJ
Hebart, H
Bader, P
Budach, W
Faul, C
Brugger, W
Kanz, L
机构：
[1] Dept Hematol & Oncol, Tubingen, Germany
[2] Dept Pediat, Tubingen, Germany
[3] Dept Radiotherapy, Tubingen, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4607
引用
收藏
页码：309B / 309B
页数：1
相关论文
共 50 条
  • [21] Velcade and high-dose melphalan: a new preparative regimen before autologous stem cell transplantation for multiple myeloma
    Danho, C
    Huynh, A
    Roussel, M
    Ysebaert, L
    Recher, C
    Huguet, FR
    Nouvel, C
    Laurent, G
    Attal, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S137 - S137
  • [22] Low dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
    Kroeger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, A
    BLOOD, 2004, 104 (11) : 457A - 458A
  • [23] Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation
    Ikeda, Takashi
    Mori, Keita
    Kawamura, Koji
    Mori, Takehiko
    Hagiwara, Shotaro
    Ueda, Yasunori
    Kahata, Kaoru
    Uchida, Naoyuki
    Tsukada, Nobuhiro
    Murakami, Satoshi
    Yamamoto, Masahide
    Takahashi, Tsutomu
    Ichinohe, Tatsuo
    Onizuka, Makoto
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Sunami, Kazutaka
    Takamatsu, Hiroyuki
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 586 - 594
  • [24] Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
    Firsova, Maya
    Mendeleeva, Larisa
    Solovev, Maxim
    Kuzmina, Larisa
    Julhakyan, Hunan
    Savchenko, Valeriy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S305 - S306
  • [25] Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
    Firsova, Maiia, V
    Mendeleeva, Larisa P.
    Parovichnikova, Elena N.
    Solovev, Maksim, V
    Kuzmina, Larisa A.
    Risinskaya, Natalia, V
    Abramova, Tatiana, V
    Galtseva, Irina, V
    Savchenko, Valerii G.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (07): : 778 - 784
  • [26] Natural-killer cell (NK)-infusion as adoptive immunotherapy in patients with multiple myeloma relapsing after allogeneic stem cell transplantation
    Wolschke, C.
    Sputtek, A.
    Stuebig, T.
    Worthmann, F.
    van Randenborgh, A.
    Ayuk, F.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S198 - S198
  • [27] Delayed stem cell transplantation in patients with relapsed or refractory multiple myeloma using thalidomide as a preparative regimen.
    Dmoszynska, A
    Hus, M
    Legiec, W
    Walter-Croneck, A
    Wach, M
    BLOOD, 2000, 96 (11) : 368B - 368B
  • [28] Fludarabine and anti thymocyte globulin (ATG) as a preparative regimen for non myeloablative peripheral stem cell transplantation in multiple myeloma patients relapsing post autologous transplantation.
    Kiss, TL
    Stewart, AK
    Lipton, J
    Xu, WM
    Messner, HA
    BLOOD, 1999, 94 (10) : 358B - 358B
  • [29] Recovery of KIR expression after allogeneic stem cell transplantation in multiple myeloma patients
    Stuebig, T.
    Liznov, M.
    Fritsche-Friedland, U.
    Alchalby, H.
    Wolschke, C.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S273 - S273
  • [30] Allogeneic stem cell transplantation for multiple myeloma
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 29 - 29
12345